Why regulatory transparency doesn’t get the “all-clear”
A recent speech by Benoit Coeuré, a member of the ECB Board of Executives, sheds some light on a key issue in the OTC derivatives markets: regulatory transparency.
This website uses technical cookies and, subject to your consent, third-party profiling cookies. You can freely give, refuse or revoke your consent at any time by accessing the cookie preferences panel, accessible from the footer. To find out more, consult the Legal notices.
